Wedgewood Recalls Selected Compounded Medicines

ADW NEWS DESK

A Doberman’s World

Wedgewood recall: check your Doberman’s medication by product and lot

ADW News Desk

Sources checked 25 October 2026

On October 21, Wedgewood announced a U.S. recall of selected unexpired compounded veterinary medicines shipped between February 18 and October 6, 2026¹. Owners who have affected product are instructed to stop using it, keep it and contact recall support¹. Contact the prescribing veterinarian if your Doberman is receiving an affected medicine; Wedgewood says individual treatment decisions should be made with that veterinarian².

THIS REPORT Product and lot Recall instructions Why the recall About this report References

Check the product and lot

Wedgewood’s SKU & Lot Lookup lets you search by product name, SKU or lot number and expand a product’s lot list³. Compare the name, strength, formulation and lot on your label with the listing.

These are selected examples from the lookup, marked “Data as of Oct 21, 2026” when checked on October 25³. They are not a complete list.

Product as listed	SKU	Lot	Expires
Pimobendan 5mg Tiny Tabs 100ct 503b	PIMOBETTB0223VC	222-08441091	February 8, 20273
Pimobendan 10mg Tiny Tabs 100ct 503b	PIMOBETTB0208VC	222-08441093	February 5, 20273
Pimobendan 5mg PS Quad tab 100ct 503b	PIMOBEQTB0086VC	222-08493897	February 23, 20273
Gabapentin 25mg Tiny Tabs 500ct 503b	GABAPETTB0115VC	222-08410051	January 29, 20273

Our table contains only a few examples. It does not cover every affected medication, strength or lot. If your Doberman’s medicine is not shown, do not assume it is unaffected. Check Wedgewood’s full product and lot list.

You can also check your medication’s lot number directly on Wedgewood’s consumer recall website. Enter the lot number from your medication label. Unlike the product list, this site returns a message stating whether the number you entered is included in the recall⁴.

Use Wedgewood’s recall instructions

Wedgewood’s information page says no action is required unless you receive an official Recall Notice identifying affected lots in your possession². The dated announcement separately instructs owners with affected product to stop use¹. If your lot matches the lookup but you have not received a notice, contact recall support and your prescriber to clarify the instructions for your supply. Not receiving a notice does not establish that your lot is unaffected.

Recall support: 866-562-5931, Monday–Friday, 8 a.m.–9 p.m. Eastern Time; Saturday, 9 a.m.–5 p.m. Eastern Time². For reimbursement instructions, Wedgewood directs owners to its official consumer recall website². Follow the notice’s instructions for keeping affected medication apart from usable stock².

Suspected side effects, lack of effectiveness or product defects can also be reported to FDA through its animal-drug reporting page⁵.

Why Wedgewood recalled these medicines

Wedgewood attributes the recall to concerns about the reliability of some laboratory testing data and the possibility of medication being weaker or stronger than intended¹. The notice identifies ineffective treatment as a potential consequence of low potency, and toxicity or overdose as potential consequences of high potency¹.

The company reported 98 complaints, seven classified as serious, in its October 21 announcement¹. The announcement gives no species or individual case details for those complaints¹. Wedgewood’s information page separately says the company has not detected a rise in complaints or adverse-event reports linked to the affected medicines². These statements describe different things: a count of reports and a claimed trend. Neither supplies a Doberman-specific injury estimate. FDA’s general reporting guidance cautions that a report does not by itself establish that a drug caused the event⁶.

About this report

ADW checked the FDA-hosted company announcement, Wedgewood’s public recall guidance, selected live lookup entries and FDA reporting guidance on 25 October 2026. The FDA page republishes Wedgewood’s announcement¹. ADW did not locate publicly accessible laboratory results or individual complaint records for this recall in the company materials and FDA records searched. Wedgewood has not been contacted for those records. The table illustrates lot-level checking and does not replace Wedgewood’s full list.

References

1. Wedgewood Pharmacy LLC. (2026, October 21). Wedgewood Pharmacy issues recall of certain compounded veterinary medications within expiry due to potential potency issues [Company announcement]. U.S. Food and Drug Administration. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/wedgewood-pharmacy-issues-recall-certain-compounded-veterinary-medications-within-expiry-due
2. Wedgewood. (n.d.). Wedgewood voluntary recall information. Retrieved October 25, 2026, from https://www.wedgewood.com/wedgewood-recall-information/
3. Wedgewood. (n.d.). SKU & lot lookup [Recall database; displayed data date October 21, 2026]. Retrieved October 25, 2026, from https://www.wedgewood.com/recall-lookup/
4. Wedgewood. (n.d.). Urgent drug recall notice: Certain compounded veterinary medications within expiry. Retrieved October 25, 2026, from https://wedgewoodrecall.expertinquiry.com/
5. Center for Veterinary Medicine. (2026, February 4). How to report animal drug and device side effects and product problems. U.S. Food and Drug Administration. https://www.fda.gov/animal-veterinary/report-problem/how-report-animal-drug-and-device-side-effects-and-product-problems
6. Center for Veterinary Medicine. (2024, April 10). Adverse event reports for animal drugs and devices. U.S. Food and Drug Administration. https://www.fda.gov/animal-veterinary/product-safety-information/adverse-event-reports-animal-drugs-and-devices

Official consumer recall website linked by Wedgewood: https://wedgewoodrecall.expertinquiry.com/

ADW NEWS DESK

Back to top